John David Hansen insider trades: Mabvax Therapeutics Holdings (MBVX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 16, 2018 | MBVX | ↓ Sell | 59,263 | $0.92 | $55K | Direct | Jan 18, 2018 (2d) |
| Jan 12, 2018 | MBVX | ↓ Sell | 192,690 | $0.97 | $186K | Direct | Jan 16, 2018 (4d) |
| May 19, 2017 | MBVX | ↑ Buy | 4,286 | $1.75 | $8K | Direct | Aug 2, 2017 (75d) |
| Apr 12, 2017 | MBVX | ↓ Sell | 10,216 | $2.00 | $20K | Direct | Apr 14, 2017 (2d) |
| Apr 11, 2017 | MBVX | ↓ Sell | 1,476 | $2.00 | $3K | Direct | Apr 11, 2017 (0d) |
| Apr 6, 2017 | MBVX | ↓ Sell | 5,051 | $2.17 | $11K | Direct | Apr 6, 2017 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John David Hansen's insider trades
John David Hansen is President and CEO at Mabvax Therapeutics Holdings (MBVX). Since Apr 6, 2017, John has reported 1 open-market purchase worth $8K and 5 sales worth $275K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), option exercises (4 filings), shares withheld for taxes (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MBVX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.